These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8582096)

  • 1. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Jackson RV; Grice JE; Hockings GI; Crosbie GV; Walters MM
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):157-61. PubMed ID: 8039271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL; Irvine CH
    Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
    Hohnloser J; Von Werder K; Müller OA
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
    Buyalos RP; Jackson RV; Grice GI; Hockings GI; Torpy DJ; Fox LM; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
    Inder WJ; Hellemans J; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):244-8. PubMed ID: 7829620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
    Grottoli S; Giordano R; Maccagno B; Pellegrino M; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of naloxone-stimulated adrenocorticotropin release by alprazolam in myotonic dystrophy patients.
    Joyner JM; Grice JE; Hockings GI; Torpy DJ; Crosbie GV; Walters MM; Jackson RV
    J Neuroendocrinol; 1998 May; 10(5):391-5. PubMed ID: 9663654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
    Grottoli S; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; DeStefanis S; Camanni F; Ghigo E; Arvat E
    J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man.
    Coiro V; Volpi R; Casti A; Maffei ML; Stella A; Volta E; Chiodera P
    Br J Clin Pharmacol; 2011 Jun; 71(6):951-5. PubMed ID: 21564163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man.
    Delitala G; Trainer PJ; Oliva O; Fanciulli G; Grossman AB
    J Endocrinol; 1994 Apr; 141(1):163-8. PubMed ID: 8031419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction.
    Donald RA; Crozier IG; Foy SG; Richards AM; Livesey JH; Ellis MJ; Mattioli L; Ikram H
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):499-504. PubMed ID: 8187316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.